In this article, a novel data-driven fault diagnosis method by combining deep canonical variate analysis and Fisher discriminant analysis (DCVA-FDA) is proposed for complex industrial processes. Inspired by the recently developed deep canonical correlation analysis, a new nonlinear canonical variate analysis (CVA) called DCVA is first developed by incorporating deep neural networks into CVA. Based on DCVA, a residual generator is designed for the fault diagnosis process. FDA is applied in the feature space spanned by residual vectors. Then, a Bayesian inference classifier is performed in the reduced dimensional space of FDA to label the class of process data. A continuous stirred-tank reactor and an industrial benchmark of the Tennessee Eastman process are carried out to test the performance of DCVA-FDA fault diagnosis. The experimental results demonstrate that the proposed DCVA-FDA fault diagnosis is able to significantly improve the fault diagnosis performance when compared to other methods also examined in this article.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: